AllianceBernstein’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-20,830
Closed -$113K 3302
2025
Q2
$113K Buy
20,830
+8,900
+75% +$44.4K ﹤0.01% 3157
2025
Q1
$41.4K Hold
11,930
﹤0.01% 3150
2024
Q4
$123K Hold
11,930
﹤0.01% 3106
2024
Q3
$162K Buy
+11,930
New +$148K ﹤0.01% 3068

Other funds holding THRD

AllianceBernstein's THRD Position: Q3 2025 in Review

AllianceBernstein sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 20,830 shares — an estimated $113K sold.

AllianceBernstein first reported a position in THRD in Q3 2024 and held it in 4 quarters. The position peaked at $162K in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • AllianceBernstein reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • AllianceBernstein sold 20,830 Third Harmonic Bio shares in Q3 2025, an estimated $113K.
  • AllianceBernstein first reported a position in Third Harmonic Bio in Q3 2024 and held it in 4 quarters.
  • AllianceBernstein's Third Harmonic Bio position peaked at $162K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on AllianceBernstein's 13F filing for Q3 2025, filed 14 Nov 2025.